Keywords: Valeant, iNova, Australia, Asica-Pacific, South Africa

Valeant to acquire Australia’s iNova for up to $946 million

Article | 22 November 2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (NYSE: VRX and TSX: VRX) has signed an agreement to buy Australia-based iNova, a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

iNova

Valeant Pharmaceuticals

Go to company listing